Deadly Diseases That Will Make Your Medical Bills Skyrocket in India
There are several deadly diseases that will make your medical bills skyrocket in India. One of the deadliest is COVID-19, which is worth nearly 16 months of a day laborer’s salary. Diabetes and hypertension are also major causes of high medical bills. A single treatment for COVID-19 can cost thousands of dollars, and the bills for treatment are often more than one year’s salary for an average Indian.
COVID-19 costs are equivalent to nearly 16 months of work for a typical Indian day laborer
The COVID-19 crisis is having a huge impact on the working lives of people in developing countries. The health effects of the disease are widespread, with employees in developing countries citing stalled growth, a lack of advancement opportunities, a loss of connection with colleagues and friends, and even serious physical health issues. As a result, women and diverse employees in emerging countries are facing greater challenges than their counterparts in developed economies.
The COVID-19 pandemic has exacerbated gender inequalities. Women are twice as likely to be affected as men by the disease. And if we assume a more negative impact on women, this disease could cost more than $1 trillion dollars by 2030.
Diabetes and hypertension cause huge medical bills
According to the National Family Health Survey (NFHS)-5, diabetics and hypertensive patients in India incur an average medical bill of Rs 8,400 a year per person. This figure increases to Rs 14,000 for diabetics who require insulin. The incidence of these diseases is also increasing. According to the report, 30 per cent of the population of India does not have health insurance and 40 per cent does not have a scheme that covers health expenses. In Gujarat, for example, the number of diabetics has doubled in just four years.
In 2010, the medical costs associated with diabetes and hypertension were $31.9 billion. This number continues to rise, particularly as complications develop. People with diabetes and hypertension incur medical bills 1.4 times higher than those without diabetes and hypertension. These two conditions are important risk factors for cardiovascular disease and chronic kidney disease. Despite their importance, diabetes and hypertension remain poorly managed in many developing countries. This is why the healthcare system in India should focus on improving the control and prevention of these conditions.
While there is a considerable number of studies addressing diabetes in India, they provide an incomplete picture of the costs of illness. Many of these studies focus on direct costs for individuals and health systems, which are not a complete picture. To perform cost-of-illness studies, a rigorous methodology is needed.
In addition to high blood pressure, hypertension is associated with other diseases, such as kidney disease and hormonal imbalances. Doctors often perform tests to detect these conditions. These tests can include blood tests to determine protein levels, urine tests to determine kidney function, ECGs to assess heart disease risk factors, and more.
Cancer costs are similar to a year’s salary for a typical Indian
In India, the cost of cancer treatment has increased dramatically over the past decade, and treatment is likely to be beyond the means of millions of people. Rising infrastructure costs, advances in technology, and newer drugs are among the factors contributing to the cost increase.
Cancer is the deadliest disease in India
Cancer is one of the most deadly diseases in India. It is also one of the leading causes of death globally. Its burden is increasing rapidly in India. It occurs when genes in the body start to malfunction. These genes are found in all cells of the body. They can cause cancer by stealing nourishment from other cells and dividing unproductively. Cancer treatment aims to get the body to recognise and destroy these abnormal cells.
The cost of cancer treatment is staggering in India, and it is especially costly in poor areas. The cost of cancer medicines alone can run up to 20,000 rupees ($400) a month. Fortunately, the government has provided assistance in this area, but it is only temporary. The cost of medicines is also exacerbated by the lack of oversight in the healthcare sector. One study found that cancer medicines were being sold at up to ten times the original price in some pharmacies.
Diabetes costs are similar to a year’s salary for a typical Indian
A typical Indian family spends about one-fourth of his or her income on diabetes care. This staggering sum is similar to the salary of a low-income worker. However, the cost of diabetes care is likely to increase over time, posing major challenges for health care financing and sustainability. The study also identified three key areas of policy intervention that could reduce the burden of diabetes and improve health care affordability.
Diabetes requires a lifelong commitment on the part of the patient and healthcare provider. It is a costly disease, requiring close monitoring and a wide variety of medical procedures. The costs involved in diabetes care include direct medical expenses, medicines and investigations, as well as indirect costs associated with diabetes management and lifestyle modification. A typical Indian family spends more than INR 27,000 on diabetes care every year.
Diabetic patients often need life-saving insulin, which can be expensive. A recent study found that a typical diabetic patient spent more than $2,500 per year on diabetes care, and one-fourth of them spent double that amount. The study also found that some patients had high deductible health plans, which contributed to their high out-of-pocket expenses.
Diabetes is an enormous financial burden for families, especially families with children. The cost of care for these children can exceed a year’s salary for a typical Indian. In addition, the disease can lead to severe hypoglycemic or ketoacidosis events, which can result in hospitalization. The high cost of diabetes care for a child can also affect other aspects of a family’s life.
Diabetes is a huge burden on society. In addition to the direct costs, diabetes incurs substantial intangible costs, including loss of productivity. These costs are difficult to quantify, but they are essential to an accurate estimate of the total cost of diabetes in a society.